The prevalence of HCM in young adults is approximately 2 per 1000, providing foundational data for population screening strategies.
HCM was present in about 2 of 1000 young adults. These unique population-based data will aid in assessments of the impact of HCM-related mortality and morbidity in the general population and the practicality of screening large populations for HCM, including those comprising competitive athletes.
Maron et al. (Tue,) studied this question.